RPG Life Sciences Limited — Updates, 29-07-2026: Other Restructuring
29-07-2026 | 11:41 pm
29-07-2026 | 11:41 pm
RPG Life Sciences spun off its API business to WOS RPGAP for ~Rs. 33.55 Cr. RPGAP secured Rs. 243.33 Cr from investors for ~40% stake, targeting up to Rs. 700 Cr for API growth. RPGAP also acquired Actis Generics for Rs. 80 Cr, boosting its API segment.
No comments yet. Be the first to comment!
